CAREERS

Discovery & Research

Other Opportunities

Myeloid Therapeutics is an immunology company focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases. With broad clinical applications possible, the Company is presently advancing its cell therapy product candidates, derived from its ATAK™ platform technology, with initial applications in T cell lymphoma and a primed monocyte approach to treating glioblastoma. The ATAK platform is scalable to multiple treatment modalities and to other disease areas in collaboration. Myeloid expects to enter the clinic with its two lead programs in the first half of 2021. The company, having operations in Cambridge, MA, was founded by Ronald Vale and Siddhartha Mukherjee.

Scientist – Immunology

We are looking for a cell biologist to identify and develop novel ATAK™ cell-based therapies and to translate these findings to the clinic. A successful candidate should have a thorough knowledge and expertise in immune cell biology and assays to characterize immune cell functions. You will work closely with scientists in discovery and translational research group to design novel receptors and characterize the ATAKTM cells in vitro functional assays and animal studies. The position represents an excellent growth and learning opportunity, working closely with experienced scientists in a fast-paced and highly collaborative environment.

© 2020,   Myeloid Therapeutics.  All rights reserved.                 Privacy Policy     |     Terms of Use     |      Cookie Policy

  • LinkedIn
  • Instagram
  • Twitter

300 Technology Square, Suite 203      |      Cambridge, Massachusetts 02139